Contributor.

Ya’ir Aizenmann
Dalberg Global Development Advisors

Ya’ir Aizenman is a senior consultant with Dalberg Global Development Advisors, where he focuses on the firm’s health care practice. In addition his work with the MDGHA, Ya’ir’s projects at Dalberg have included writing a design and process evaluation of the Pneumococcal AMC, a $1.5B financing initiative to purchase pneumococcal vaccines for low-income countries; helping the US Mission in Haiti develop a balanced scorecard to track its progress in assisting with post-earthquake reconstruction; and developing an analysis for the GAVI Alliance comparing the economics of second-generation vaccine producers and generic drug manufacturers.

Before Dalberg, Ya’ir worked at the Clinton Health Access Initiative (CHAI), where he co-wrote, with Paul Wilson, Value for Money in Malaria Programming: Issues and Opportunities, a CGD working paper examining ways to improve the cost-effectiveness of global malaria efforts. Before joining CHAI, Ya’ir worked for D.E. Shaw, a New York-based investments manager. Ya’ir has an AB in computer science from Harvard University.

Articles by Ya’ir Aizenmann